35 Years of Psychedelic Science

This April, the Multidisciplinary Association for Psychedelic Studies (MAPS) is celebrating the 35th anniversary of being a non-profit research and educational organization that develops medical, legal, …

FY 2019-2020 Financial Report

MAPS Bulletin Autumn 2020: Vol. 30, No. 3 Download this article. By: Merete Christiansen, MAPS Associate Director of Development Rick Doblin, Ph.D., MAPS Founder and Executive Director Tess Marin Shelley, …

Drug Decriminalization: Election Results and Articles

November’s election results signaled that Americans are increasingly ready for alternatives to the War on Drugs, and reconsidering society’s relationship with drugs. American voters continue …

Drug Reform is on the Ballot

Despite momentous progress developing legal psychedelic medicines, drug possession is still the number one reason for arrest in the United States. FDA-approved medical access to psychedelics is only a …

Policy & Advocacy

The MAPS Policy & Advocacy Department advocates for healing and justice. We work to eliminate barriers to psychedelic research, education, and care. We envision legal paradigms for psychedelic use …